Bellerophon Therapeutics Inc buy melinda
Start price
12.02.17
/
50%
€9.76
Target price
14.02.17
€10.82
Performance (%)
28.93%
End price
14.02.17
€12.58
Summary
This prediction ended on 14.02.17 with a price of €12.58. The BUY prediction by melinda finished with a performance of 28.93%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bellerophon Therapeutics Inc | - | - | - | - |
iShares Core DAX® | -1.370% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.801% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.369% | -2.979% | 26.341% | 40.911% |
Comments by melinda for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
Lungenfibrose
a +
(Zielkurs erreicht)
Stopped prediction by melinda for Bellerophon Therapeutics Inc
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€8.66
25.05.19
25.05.19
€16.24
04.11.21
04.11.21
-96.60%
04.01.21
04.01.21
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€36.53
16.12.17
16.12.17
€40.59
18.06.18
18.06.18
-9.26%
18.06.18
18.06.18
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€40.50
16.12.17
16.12.17
€45.00
18.06.18
18.06.18
-9.26%
18.06.18
18.06.18
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€25.91
08.03.17
08.03.17
€33.83
08.09.17
08.09.17
-39.41%
08.09.17
08.09.17
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€15.83
21.02.17
21.02.17
€27.06
27.02.17
27.02.17
12.82%
27.02.17
27.02.17